– Webcast to be Held at 8:00 am ET on February 22, 2024 – NEW YORK, Feb. 15, 2024 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today…